ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 68 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $183,000 | -83.2% | 748,583 | -80.3% | 0.00% | -100.0% |
| Q1 2022 | $1,088,000 | -47.8% | 3,808,993 | +2.3% | 0.00% | -50.0% |
| Q4 2021 | $2,085,000 | -38.3% | 3,721,586 | +12.3% | 0.00% | -33.3% |
| Q3 2021 | $3,380,000 | -48.6% | 3,314,079 | -30.5% | 0.00% | -50.0% |
| Q2 2021 | $6,580,000 | -26.3% | 4,768,524 | -9.2% | 0.01% | -33.3% |
| Q1 2021 | $8,923,000 | +695.3% | 5,248,879 | +479.8% | 0.01% | +800.0% |
| Q4 2020 | $1,122,000 | -4.4% | 905,266 | +9.5% | 0.00% | 0.0% |
| Q3 2020 | $1,174,000 | -6.0% | 826,902 | -19.9% | 0.00% | 0.0% |
| Q2 2020 | $1,249,000 | +43.1% | 1,031,840 | +39.5% | 0.00% | 0.0% |
| Q1 2020 | $873,000 | -12.5% | 739,744 | +56.4% | 0.00% | 0.0% |
| Q4 2019 | $998,000 | -48.6% | 472,985 | -46.4% | 0.00% | -50.0% |
| Q3 2019 | $1,941,000 | -10.8% | 882,146 | +2.6% | 0.00% | -33.3% |
| Q2 2019 | $2,175,000 | +117.7% | 859,971 | +199.8% | 0.00% | +200.0% |
| Q1 2019 | $999,000 | +640.0% | 286,832 | +391.9% | 0.00% | – |
| Q4 2018 | $135,000 | -80.6% | 58,315 | -67.7% | 0.00% | -100.0% |
| Q3 2018 | $695,000 | -17.7% | 180,438 | -27.8% | 0.00% | 0.0% |
| Q2 2018 | $844,000 | +148.2% | 249,992 | +54.5% | 0.00% | – |
| Q1 2018 | $340,000 | +159.5% | 161,822 | +149.8% | 0.00% | – |
| Q4 2017 | $131,000 | -59.3% | 64,783 | -7.4% | 0.00% | – |
| Q3 2017 | $322,000 | +28.8% | 69,931 | -39.8% | 0.00% | – |
| Q2 2017 | $250,000 | -30.9% | 116,092 | +0.9% | 0.00% | -100.0% |
| Q1 2017 | $362,000 | -7.2% | 115,047 | -23.4% | 0.00% | 0.0% |
| Q4 2016 | $390,000 | -57.7% | 150,131 | -36.7% | 0.00% | -50.0% |
| Q3 2016 | $922,000 | +35.2% | 237,057 | -6.5% | 0.00% | +100.0% |
| Q2 2016 | $682,000 | -17.4% | 253,468 | -5.5% | 0.00% | 0.0% |
| Q1 2016 | $826,000 | -36.3% | 268,122 | -20.3% | 0.00% | -50.0% |
| Q4 2015 | $1,296,000 | +121.2% | 336,622 | +75.1% | 0.00% | +100.0% |
| Q3 2015 | $586,000 | +5.2% | 192,281 | +46.3% | 0.00% | 0.0% |
| Q2 2015 | $557,000 | -33.3% | 131,391 | -39.2% | 0.00% | 0.0% |
| Q1 2015 | $835,000 | -47.9% | 216,151 | -9.3% | 0.00% | -50.0% |
| Q4 2014 | $1,604,000 | +2618.6% | 238,312 | +2117.3% | 0.00% | – |
| Q3 2014 | $59,000 | -83.7% | 10,748 | -66.4% | 0.00% | – |
| Q4 2013 | $362,000 | +62.3% | 31,971 | +54.2% | 0.00% | – |
| Q3 2013 | $223,000 | – | 20,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |